Literature DB >> 12938223

Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors.

Nurit Yachimovich-Cohen1, Ruth Fischel, Neta Bachar, Yuval Yarkoni, Dan Eilat.   

Abstract

We have previously constructed knock-in (C57BL/6xBALB/c) F1 mice, each expressing an anti-DNA heavy (H) chain (D42), combined with one of three different light (L) chains, namely Vkappa1-Jkappa1, Vkappa4-Jkappa4 or Vkappa8-Jkappa5. All of these H/L chain combinations bind DNA with similar affinity and fine specificity. However, while mice carrying Vkappa1-Jkappa1-transgenic L chain were tolerized almost exclusively by L chain receptor editing, the mice expressing Vkappa8-Jkappa5 L chains utilized clonal anergy as their principal mechanism of B cell tolerance. Vkappa4-Jkappa4 targeted mice exhibited an intermediate phenotype. In the present study, these three H/L chain combinations were backcrossed onto the autoimmune NZB/NZW F1 mice. We find that the mechanism of clonal anergy is abrogated in these mice, but that receptor editing is maintained. Moreover, diseased NZB/NZW mice utilize L chain secondary rearrangements for the generation of high-affinity, anti-dsDNA-producing B cells from low-affinity precursors. The edited B cell clones are not deleted or anergized in the autoimmune animal; rather they are selected for activation, class-switching and affinity maturation by somatic mutation. These results suggest that B cell receptor editing plays an important role not only in tolerance induction, but also in generating high-affinity autoreactive B cells in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12938223     DOI: 10.1002/eji.200324025

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  B cell tolerance and positive selection in lupus.

Authors:  Dan Eilat; Matthias Wabl
Journal:  J Immunol       Date:  2012-07-15       Impact factor: 5.422

Review 2.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Loss of an IgG plasma cell checkpoint in patients with lupus.

Authors:  Jolien Suurmond; Yemil Atisha-Fregoso; Emiliano Marasco; Ashley N Barlev; Naveed Ahmed; Silvia A Calderon; Mei Yin Wong; Meggan C Mackay; Cynthia Aranow; Betty Diamond
Journal:  J Allergy Clin Immunol       Date:  2018-11-13       Impact factor: 10.793

4.  Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE.

Authors:  Thiago Detanico; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Autoimmun       Date:  2015-01-26       Impact factor: 7.094

5.  Regulation of the B cell receptor repertoire and self-reactivity by BAFF.

Authors:  Miyo Ota; Bao H Duong; Ali Torkamani; Colleen M Doyle; Amanda L Gavin; Takayuki Ota; David Nemazee
Journal:  J Immunol       Date:  2010-09-03       Impact factor: 5.422

Review 6.  Mechanisms of central tolerance for B cells.

Authors:  David Nemazee
Journal:  Nat Rev Immunol       Date:  2017-04-03       Impact factor: 53.106

7.  BAFF/APRIL inhibition decreases selection of naive but not antigen-induced autoreactive B cells in murine systemic lupus erythematosus.

Authors:  Weiqing Huang; Ioana Moisini; Ramalingam Bethunaickan; Ranjit Sahu; Meredith Akerman; Dan Eilat; Martin Lesser; Anne Davidson
Journal:  J Immunol       Date:  2011-11-18       Impact factor: 5.422

Review 8.  Somatic mutagenesis in autoimmunity.

Authors:  Thiago Detanico; James B St Clair; Katja Aviszus; Greg Kirchenbaum; Wenzhong Guo; Lawrence J Wysocki
Journal:  Autoimmunity       Date:  2013-01-18       Impact factor: 2.815

9.  Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity.

Authors:  Wenzhong Guo; Diana Smith; Katja Aviszus; Thiago Detanico; Ryan A Heiser; Lawrence J Wysocki
Journal:  J Exp Med       Date:  2010-08-30       Impact factor: 14.307

10.  Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir.

Authors:  Gabriele B Beck-Engeser; Dan Eilat; Thomas Harrer; Hans-Martin Jäck; Matthias Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.